WEB SEARCH


TOP SELECTION

CONTACT US

info_demofinance@mynasdaq.it

DONATION

All profits of this web site are donated to charity 'the arsenal of peace'. VISIT THE WEBSITE

ADS

Complete financial analysis of ILLUMINA INC (ILMN)

Name ILLUMINA INC
Year low 25.57
Year High 79.40
Symbol ILMN
Last trade 43.85
Percentage change 0.00
Volume 201
Media Volume (3m) 2,952,240
PE Ratio 66.54
EPS 0.659
Market Cap 5413
Media fatt 1011
Trend fatt trend fatt graph for ILLUMINA INC
Media net income 77
Trend net income trend net income for ILLUMINA INC
P / E P / E graph for ILLUMINA INC - 0 points 0
EPS EPS graph for ILLUMINA INC - 11 points 11
MARKET CAP / TOTAL REVENUE market cap / total revenue graph for ILLUMINA INC - 0 points 0
TOT REV 1 / TOT REV 2 TOT REV 1 / TOT REV 2 graph for ILLUMINA INC - 7 points 7
NET INC 1 / NET INC 2 NET INC 1 / NET INC 2 graph for ILLUMINA INC - 12 points 12
MED NET INC / MED TOT REV MED NET INC / MED TOT REV graph for ILLUMINA INC - 4 points 4
NET INCOME / MARKET CAP NET INCOME / MARKET CAP graph for ILLUMINA INC - 1 points 1
TOTALREV1/TOTALREV3 totalRev1/totalRev3 graph for ILLUMINA INC - 7 points 7
NET INC1/NET INC3 net inc1/net inc3 graph for ILLUMINA INC - 8 points 8
TOT REV 2/ TOT REV 3 tot rev 2/ tot rev 3 graph for ILLUMINA INC - 5 points 5
NET INC 2 / NET INC 3 net inc 2 / net inc 3 graph for ILLUMINA INC - 0 points 0
. . graph for ILLUMINA INC - 0 points 0
MARKET CAP / NET TANGIBLE ASSETS MARKET CAP / NET TANGIBLE ASSETS graph for ILLUMINA INC - 1 points 1
MARK CAP/TOT STOCK EQ MARK CAP/TOT STOCK EQ graph for ILLUMINA INC - 0 points 0
MARKET CAP / TOT CURRENT ASSETS market cap / tot current assets graph for ILLUMINA INC - 0 points 0
TOT CURR ASSETS / TOT LIAB TOT CURR ASSETS / TOT LIAB graph for ILLUMINA INC - 3 points 3
. . graph for ILLUMINA INC - 0 points 0
SELL HOLD BUY SELL HOLD BUY graph for ILLUMINA INC - 0 points 0
SINTESE 59

GRAPHS

max price logarithm graph for ILLUMINA INC based on no conditions max volume linear graph for ILLUMINA INC based on no conditions

News

4 Highly Liquid Biotech Stocks With Bullish Short Trends (May 10 - reuters) Illumina to Webcast Live Presentations at Upcoming Investment Conferences in May (May 02 - reuters) Buy, Sell, or Hold: Sequenom (Apr 25 - reuters) Illumina Introduces BaseSpace Apps, Solutions for Genome Informatics (Apr 25 - reuters) Illumina Tries To Get The Kool-Aid Flowing Again (Apr 24 - reuters) Illumina Beats on Both Top and Bottom Lines (Apr 24 - reuters) Illumina Launches MyGenome App for iPad (Apr 24 - reuters) Illumina's CEO Discusses Q1 2012 Results - Earnings Call Transcript (Apr 24 - reuters) Illumina posts better-than-expected 1st-qtr profit (Apr 24 - reuters) UPDATE 1-Illumina posts better-than-expected 1st-qtr profit (Apr 24 - reuters) Illumina posts better-than-expected first-quarter profit (Apr 24 - reuters) Illumina Reports Financial Results for First Quarter of Fiscal Year 2012 (Apr 23 - reuters) Illumina And Human Genome: Reasons For Rejections Of Takeovers (Apr 23 - reuters) Market Chatter - Corporate finance press digest (Apr 23 - reuters) Illumina Stays Independent But Drops As Roche's Offer Expires (Apr 22 - reuters) Roche talks to Illumina rivals after drops bid: paper (Apr 22 - reuters) Roche ready to walk away from $6.8 billion Illumina bid (Apr 18 - reuters) Illumina Announces Preliminary Voting Results for 2012 Annual Meeting of Stockholders (Apr 18 - reuters) Roche Can't Sequence $6.8 Illumina Deal (Apr 18 - reuters) DEALTALK-Ditching Illumina might help Roche long term (Apr 18 - reuters) Health Care Report Connects Dots Between Genomic Research And Patient Records (Apr 17 - reuters) Illumina to Announce First Quarter 2012 Results on Monday, April 23, 2012 (Apr 16 - reuters) It's Time to Start Buying Into the Next Bubble (Apr 13 - reuters) Steady As She Goes For Roche (Apr 12 - reuters) Roche Q1 sales flat as Illumina bid battle rages (Apr 12 - reuters) Roche Q1 sales flat as Illumina bid battle rages (Apr 12 - reuters) RPT-UPDATE 1-Roche Q1 sales flat as Illumina bid battle rages (Apr 12 - reuters) UPDATE 1-Roche Q1 sales flat as Illumina bid battle rages (Apr 12 - reuters) Swiss stocks - Factors to watch on April 12 (Apr 12 - reuters) Roche calls offer for Illumina "starting point" (Apr 12 - reuters) Third proxy firm backs Illumina board members (Apr 10 - reuters) Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote for the Election of All Illumina Nominees Using Management`s WHITE Proxy Card (Apr 10 - reuters) Illumina`s Board of Directors Sends Fourth Letter to Stockholders (Apr 09 - reuters) Roche may boost bid for Illumina after rebuff (Apr 07 - reuters) ISS urges Illumina holders to reject Roche proposals (Apr 06 - reuters) UPDATE 1-ISS urges Illumina holders to reject Roche proposals (Apr 06 - reuters) Leading Proxy Advisory Firms Issue Reports in Strong Support of Illumina (Apr 06 - reuters) UPDATE 2-Roche steps up overtures in Illumina bid battle (Apr 04 - reuters) Roche steps up overtures in Illumina bid battle (Apr 04 - reuters) RPT-UPDATE 1-Roche steps up pressure in Illumina bid battle (Apr 04 - reuters) UPDATE 1-Roche steps up pressure in Illumina bid battle (Apr 04 - reuters) Illumina`s Board of Directors Sends Third Letter to Stockholders (Apr 03 - reuters) Illumina board rejects sweetened Roche offer (Apr 03 - reuters) UPDATE 1-Roche urges Illumina investors to push for bid talks (Apr 03 - reuters) Roche urges Illumina investors to push for bid talks (Apr 03 - reuters) Roche says disappointed by Illumina bid rejection (Apr 03 - reuters) Illumina board rejects sweetened Roche offer (Apr 02 - reuters) Illumina board rejects sweetened Roche offer (Apr 02 - reuters) Illumina`s Board Unanimously Rejects Roche`s Revised Unsolicited Offer (Apr 02 - reuters) Illumina Announces Preliminary Revenue for First Quarter 2012 (Apr 02 - reuters)

ADS

MY PORTFOLIO



GAIN vs LOSS


BEST vs WORST


SELECTION DIY

Market Cap
Last Trade
Gain/Loss
Webtech:
P / E
EPS
market cap / total revenue
TOT REV 1 / TOT REV 2
NET INC 1 / NET INC 2
MED NET INC / MED TOT REV
NET INCOME / MARKET CAP
totalRev1/totalRev3
net inc1/net inc3
tot rev 2/ tot rev 3
net inc 2 / net inc 3
.
MARKET CAP / NET TANGIBLE ASSETS
MARK CAP/TOT STOCK EQ
market cap / tot current assets
TOT CURR ASSETS / TOT LIAB
.
SELL HOLD BUY